A Phase II, Dose-escalating, Randomized, Double-blind, Multicenter Study to Evaluate the Efficacy, Safety and Pharmacokinetic Profile of MDT-10013 Versus Standard of Care in the Treatment of Acute Postoperative Pain Following Bunionectomy
Phase of Trial: Phase II
Latest Information Update: 15 Oct 2017
Price : $35 *
At a glance
- Drugs MDT 10013 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Medtronic
- 15 Apr 2016 Status changed from active, no longer recruiting to completed.
- 19 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 15 Jul 2015 Planned End Date changed from 1 Nov 2015 to 1 Mar 2016 as per ClinicalTrials.gov record.